Cargando…
Associations of statin use with 30-day adverse outcomes among 4 801 406 US Veterans with and without SARS-CoV-2: an observational cohort study
OBJECTIVE: To estimate associations of statin use with hospitalisation, intensive care unit (ICU) admission and mortality at 30 days among individuals with and without a positive test for SARS-CoV-2. DESIGN: Retrospective cohort study. SETTING: US Veterans Health Administration (VHA). PARTICIPANTS:...
Autores principales: | Wander, Pandora L, Lowy, Elliott, Beste, Lauren A, Tulloch-Palomino, Luis, Korpak, Anna, Peterson, Alexander C, Kahn, Steven E, Danaei, Goodarz, Boyko, Edward J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889446/ https://www.ncbi.nlm.nih.gov/pubmed/35304400 http://dx.doi.org/10.1136/bmjopen-2021-058363 |
Ejemplares similares
-
Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19
por: Wander, Pandora L., et al.
Publicado: (2021) -
The Incidence of Diabetes Among 2,777,768 Veterans With and Without Recent SARS-CoV-2 Infection
por: Wander, Pandora L., et al.
Publicado: (2022) -
Risk factors for adverse outcomes among 35 879 veterans with and without diabetes after diagnosis with COVID-19
por: Wander, Pandora L, et al.
Publicado: (2021) -
SARS-CoV-2 infection is associated with higher odds of insulin treatment but not with hemoglobin A1c at 120 days in U.S. Veterans with new-onset diabetes
por: Wander, Pandora L., et al.
Publicado: (2023) -
Estimated excess acute-care length of stay and extra cost of testing-based versus symptom-based isolation strategies among veterans hospitalized with coronavirus disease 2019 (COVID-19) discharging to a congregate setting
por: Wu, Chenwei, et al.
Publicado: (2020)